PGR and neoplasm: Another promising candidate, [18F]FPTT, demonstrated good specificity in a preclinical study by Gao et al., showing significantly higher uptake in PR-positive tumors compared to PR-negative ones, with its specificity validated by a blocking study in vivo and an increased tumor uptake following estradiol stimulation.